Tirzepatide vs Ozempic

Medications for weight loss management in obese individuals are of the top searches nowadays. Lay persons may find it difficult to comprehend and compare the scientific facts and proven findings on Tirzepatide vs Ozempic. Hence, which one is better, the former or the latter?

Patients and healthcare professionals are focusing on the Tirzepatide vs Ozempic comparison because of the increased interest in weight loss therapies for type-2 diabetes and obesity. Both drugs have demonstrated the potency to:

Lower blood glucose (sugar) levels
Promote weight loss

To make a rational decision, SlimNow MD explains the debate between Tirzepatide vs Ozempic, their modes of action, and proven findings.

Learn more about weight loss injections.

The Fundamentals of Tirzepatide and Ozempic

Ozempic is a brand name that sells Semaglutide. It is a glucagon-like peptide-1 (GLP-1) receptor agonist. The FDA has authorized Ozempic for the treatment of:

Type-2 diabetes
Cardiovascular risk in heart patients

Brand names ‘Zepbound’ and ‘Mounjaro’ are the core sellers of Tirzepatide. This medication is a dual agonist of the:

Glucose-dependent insulinotropic polypeptide (GIP) receptor
GLP-1 receptor

How Do Tirzepatide and Ozempic Work?

Both components imitate the GLP-1 hormone. They aid in:

Controlling hunger
Insulin production
Digestion

By mimicking the GLP-1 hormone, these medications help regulate blood sugar levels and support weight loss. They slow down gastric emptying, which promotes fullness and reduces calorie intake. This dual effect makes them effective tools for managing type-2 diabetes and obesity.

Tirzepatide injections also stimulate the GIP receptor, contributing to metabolic control in another way. For some patients, this dual action may increase its efficacy.

Clinical Performance

In head-to-head clinical studies, Tirzepatide was marginally more effective than Ozempic at lowering HbA1c levels. For instance:

Ozempic lowered HbA1C by 1.86%.
Tirzepatide reduced it by up to 2.3%

This difference, while modest, can be significant for individuals aiming for tighter blood sugar control. The added benefits of Tirzepatide may make it a preferred option for some patients. However, individual response and tolerability should guide treatment decisions.

Similarly, Tirzepatide seems to have better weight loss results in many cases. However, individual results may differ.

Tolerability and Side Effects

Both medications present some common adverse effects:

Diarrhea
Vomiting
Nausea

These side effects are usually mild and tend to improve as your body adjusts to the medication. However, if they persist or become severe, it is important to consult your healthcare provider. Staying hydrated and following dosage instructions can help manage these symptoms effectively.

The dual hormonal action of Tirzepatide may be the reason why some people experience less or milder side effects. Notably, doses are not interchangeable. Neither medicine should be used with another GLP-1 prescription.

Administration and Availability

For now, Tirzepatide is only available as an injectable. Ozempic is available as a weekly injection and in oral form. You can easily self-administer the prescribed medicine at home. These are injected subcutaneously, usually in the upper arm, thigh, or stomach. Due to high demand, both medicines are often in shortage. In addition, insurance coverage differs, especially if the prescription is only for weight loss.

Cardiovascular Aspects

Ozempic offers bonus advantages for decreased risk of heart attack and stroke in patients. Preliminary evidence indicates that Tirzepatide may also promote heart health by lowering blood pressure. However, this is currently being researched.